Asston Pharmaceuticals Ltd
Price Range
₹115 - ₹123
-
Min. Quantity
2,000 Shares
Closes on
11 July 2025
-
Min. investment
₹2,46,000
Asston Pharmaceuticals Ltd IPO Timeline
Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020 was promoted by Dr. Ashish Sakalkar and Mr. Sachin Badakh. Finally, 'Asston Pharmaceuticals Private Limited' was converted from a Private Limited into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.
| Event | Date |
|---|---|
| Asston Pharmaceuticals Ltd IPO Opening Date | 9 July 2025 |
| Asston Pharmaceuticals Ltd IPO Closing Date | 11 July 2025 |
| Basis of Allotment | 14 July 2025 |
| Initiation of Refunds | 15 July 2025 |
| Credit of Shares to Demat | 15 July 2025 |
| Asston Pharmaceuticals Ltd IPO Listing Date | 16 July 2025 |
Asston Pharmaceuticals Ltd IPO Details
| Asston Pharmaceuticals Ltd IPO Date | 9 July 2025 to 11 July 2025 |
| Asston Pharmaceuticals Ltd IPO Face Value | ₹10 per share |
| Asston Pharmaceuticals Ltd IPO Price | ₹115 to ₹123 per share |
| Asston Pharmaceuticals Ltd IPO Lot Size | 2,000 |
| Issue Size | Shares of ₹10 (aggregating up to ₹27.56 Cr) |
| Fresh Issue | Shares of ₹10 (aggregating up to ₹27.56 Cr) |
| Offer for Sale | - |
| Issue Type | Book Building - SME |
| Listing At | BSE - SME |
| QIB Shares Offered | Not more than 4,25,000 of the Net Offer |
| Retail Shares Offered | Not less than 7,46,000 of the Net Offer |
| NII (HNI) Shares Offered | Not less than 3,22,000 of the Net Offer |
| Company Promoters | Ashish Narayan Sakalkar, Saili Jayaram More, Sachin Chandrakant Badakh |
Asston Pharmaceuticals Ltd IPO Lot Size
The Asston Pharmaceuticals Ltd IPO lot size is 2,000 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 2,000 | ₹2,46,000 |
| Maximum | - | 0 | ₹0 |
- Strengths
- Risks
- Opportunities
- Formulation Expertise.
- Experienced Promoters.
- Wide range of Products.
- Strategic Location.
- Skilled Workforce.
- Good relationship with contract manufacturers.
- Quality Assurance.
- Good relationship with clients in the export market.
- Competitive Pricing.
- Asset Light Model.
Company Financials
Asston Pharmaceuticals Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2024 | 20.26 | 15.84 | 1.36 |
| 03-2023 | 13.69 | 7.19 | 1.06 |
| 03-2022 | 9.49 | 10.55 | 0.11 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
- Funding the incremental working capital requirements of our company
- Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
- General corporate purposes
Asston Pharmaceuticals Ltd IPO Promoter Holding
| Pre Issue Share Holding | 29.54% |
| Post Issue Share Holding | 21.77% |
Asston Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)
The Asston Pharmaceuticals Ltd IPO is subscribed 124.3601 times on 11 July 2025 05:00:00 PM. The public issue subscribed 172.1394 times in the retail category, 85.7624 times in the QIB category, and 353.4969 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
| Subscription (times) | 85.7624 | 353.4969 | 172.1394 | - | 124.3601 |
Asston Pharmaceuticals Ltd IPO Prospectus
Asston Pharmaceuticals Ltd IPO Listing Date
| BSE Script | 544445 |
| NSE Symbol | - |
| Listing In | BSE - SME |
| ISIN | INE0SJX01015 |
| IPO Price | ₹123 |
| Face Value | ₹10 |
Company Contact Information
4th Flr Office No.A-431 BalajiBhavan Plot No.42A Sec-11 CBD,Mumbai-400614
Phone: +91 22 4973 1411/+91 22 4973 1419
Email: info@asstonpharmaceuticals.com
Website: www.asstonpharmaceuticals.com
Asston Pharmaceuticals Ltd IPO Registrar
Asston Pharmaceuticals Ltd IPO Lead Manager(s)
- Sobhagya Capital Options Pvt. Ltd.
FAQ
What is the issue size of Asston Pharmaceuticals Ltd IPO?
I have pre-applied for Asston Pharmaceuticals Ltd IPO. When will my order get placed?
In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.